《复牌表现》新威(00058.HK)曾飙逾2倍探顶 主席溢价25%增购股份触提全购
新威国际(00058.HK)主席溢价25%增购股份触发提全购,该股停牌逾一个月後今早复牌最多飙升2.1倍至0.248元,创逾年半高无以为继,升幅大幅收窄至69%,报0.135元,成交急增至4,746万股,为逾八个月最多,涉资786万元。
新威公布,以每股0.1元(较停牌前溢价20%)向主要股东兼主席詹世佑发行1.49亿股新股或占扩大後股本16.6%,所得净额1,390万元将用作一般营运资金。完成後,詹氏及其一致行动人士持股将由目前29.92%增至41.54%,须按例以同价提出强制有条件全面要约,料涉资约5,300万元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.